Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a maintenance release with no visible changes to the study details.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a small platform update to the page's metadata.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated to v3.6.3, replacing the previous v3.6.2, indicating a new version of the ClinicalTrials.gov page.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now shows revision v3.6.2 instead of v3.6.0 in the footer, indicating a small maintenance update.SummaryDifference0.1%

- Check75 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision tag updated to v3.6.0, with the older v3.5.5 removed. A recruitment status note No longer looking for participants appears, signaling termination due to low accrual.SummaryDifference0.5%

- Check82 days agoChange DetectedThe page revision tag was updated to v3.5.5, indicating a newer version of the page or site software. This change appears to be a maintenance update and does not modify the study details or other user-facing content.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.